OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective	312
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration	289
Inflammation in Glaucoma: From the back to the front of the eye, and beyond	214
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations	198
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders	170
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities	166
Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)	164
VEGFR1 signaling in retinal angiogenesis and microinflammation	161
Efficacy in myopia control	149
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities	148
Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis	119
Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety	115
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis	110
Corneal endothelial dysfunction: Evolving understanding and treatment options	105
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy	101
Early and late stage gene therapy interventions for inherited retinal degenerations	100
Posterior capsule opacification: What's in the bag?	95
Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses	94
Normal and glaucomatous outflow regulation	91
Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features	91
Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities	86
The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies	82
Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances	80
Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina	80
Extracellular vesicle therapy for retinal diseases	79

Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography	77
Choriocapillaris: Fundamentals and advancements	72
Past, present and future role of retinal imaging in neurodegenerative disease	72
Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets	71
Artificial intelligence in OCT angiography	69
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration	69
Corneal stromal repair and regeneration	68
Fundus autofluorescence imaging	67
Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials	64
Adaptive responses to neurodegenerative stress in glaucoma	64
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases	63
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	62
Metastatic uveal melanoma: The final frontier	62
Human limbal epithelial stem cell regulation, bioengineering and function	62
Regenerative therapy for the Cornea	60
Retinal energy metabolism in health and glaucoma	60
Uncoupling proteins in the mitochondrial defense against oxidative stress	59
Dominant optic atrophy: Culprit mitochondria in the optic nerve	58
Discovery and clinical translation of novel glaucoma biomarkers	58
Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections	57
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma	57
The vital role for nitric oxide in intraocular pressure homeostasis	56
Vitreous and Vision Degrading Myodesopsia	55
The innate immune system in diabetic retinopathy	55
Pathogenesis of ocular toxoplasmosis	53
TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease	52
Cell fate decisions, transcription factors and signaling during early retinal development	51
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	50
Retinal vessel diameters and function in cardiovascular risk and disease	50
Retinal pigment epithelium 65 kDa protein (RPE65): An update	47
Aqueous outflow regulation – 21st century concepts	46
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions	46
Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy	45
Prospects for the application of Müller glia and their derivatives in retinal regenerative therapies	44
Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula	44
Zinn's zonule	44